Trade OGEN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Oragenics Inc. (OGEN) is trading at US$0.53, up 0.19% today as of Aug 28, 11:36 EDT. The company has a market capitalisation of US$2.37M. Over the past 52 weeks, OGEN has traded between US$0.48 and US$1.45. On Syfe you can trade OGEN with $0 commission and add it to your watchlist.
| Previous close | US$0.53 |
|---|---|
| Market cap | US$2.37M |
| 52-week range | US$0.48 – US$1.45 |
| Volume | 29.57K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Oragenics Inc.
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Lakewood Ranch, FL.
Year: 2003
Oragenics Says All Three Australian Concussion Trial Sites Enrolling Patients
Jul 7, 1:07 PM · MT Newswires
Oragenics Inc. (OGEN) stock is trading at US$0.53, +0.19% from the previous close of US$0.53.
The market cap for Oragenics Inc. (OGEN) stock is approximately US$2.37M.
The 52-week high for Oragenics Inc. (OGEN) stock is US$1.45.
The 52-week low for Oragenics Inc. (OGEN) stock is US$0.48.
Oragenics Inc. (OGEN) does not currently pay a dividend.
Stay on top of OGEN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
